Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis

Oncogenic RAS is a critical driver for the initiation and progression of several types of cancers. However, effective therapeutic strategies by targeting RAS, in particular RAS(G12D) and RAS(G12V), and associated downstream pathways have been so far unsuccessful. Treatment of oncogenic RAS-ravaged c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cell Death Dis
Autores principales: Liu, Muyun, Wang, Dan, Luo, Yongde, Hu, Lianghao, Bi, Yawei, Ji, Juntao, Huang, Haojie, Wang, Guoqiang, Zhu, Liang, Ma, Jianjia, Kim, Eunice, Luo, Catherine K., Abbruzzese, James L., Li, Xiaokun, Yang, Vincent W., Li, Zhaoshen, Lu, Weiqin
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7887267/
https://ncbi.nlm.nih.gov/pubmed/33594044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-021-03473-6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares